文章
醫療新知 > 癌細胞清除乾淨沒 這枝筆輕輕一掃便知

癌細胞清除乾淨沒 這枝筆輕輕一掃便知

07-09-2017

 

(中央社華盛頓6日綜合外電報導)癌症患者動手術時最擔心的莫過於外科醫師未將腫瘤清除乾淨,專家現在已經研發出一種新型筆狀工具,能將這樣的憂慮一掃而空。



法新社報導,美國德州大學奧斯汀分校(University of Texas at Austin)科學家和工程師研發的這項工具稱為「質譜筆」(MasSpec Pen,暫譯),能讓移除腫瘤的外科醫師在幾秒內就能偵測出組織裡的癌細胞,讓醫師立刻知道自己是否已經發現且移除所有癌細胞。


目前要花上好幾天時間才能確定外科醫師是否切除所有癌細胞;如果有所遺漏,可能會導致患者癌症復發,或至少必須再動一次手術來將病變細胞清乾淨。


美聯社引述研究主筆、德州大學奧斯汀分校化學副教授厄伯林(Livia Eberlin)表示,每個人最大夢魘,莫過於動刀後仍有癌細胞殘留的可能性,「透過提供即時分子資料,我們真的可以提高精準度」。


「科學轉譯醫學」(Science Translational Medicine)今天刊登的研究指出,這種筆在手術中只需10秒左右的時間就能辨識出癌組織。


手術期間用質譜筆接觸組織,輕輕引出小分子,再透過筆尖探針內建的小型質譜儀來進行分析。它能透過一種稱為代謝物(metabolites)的獨特分子來辨識癌細胞。


研究說:「每種癌症都會產生一組獨特的代謝物和其他作用有如指紋的生物標記。」


質譜筆能在幾秒內辨識出殘餘的癌細胞,連接質譜筆的監視器會顯示細胞為「正常」或是「癌」。這讓外科醫師得以繼續清除癌細胞,直到幾乎確定已經清除所有癌細胞為止;對於哪個組織要留在患者體內,醫師也能做出更好的判斷。

 


根據這項研究,自253名人類癌症患者身上移除的組織檢測顯示,這種新型工具的「準確率超過96%」。

http://www.cna.com.tw/news/ahel/201709070184-1.aspx

 

 

zhang2HR

The MasSpec Pen is a handheld probe that can non-destructively analyze human tissue samples to identify cancer. Vivian Abagiu/Univ. of Texas at Austin

This Pen Can Diagnose Cancer in 10 Seconds

Sep 06, 2017

TIME Health

For more, visit TIME Health.

When it comes to treating cancer, surgeons want to get rid of as much cancerous tissue as possible during tumor removal. Now a new technology—the size of a pen—is attempting to make that easier by distinguishing between tumors and healthy tissue in just 10 seconds.

The MasSpec Pen is a real-time diagnostic tool created by researchers at the University of Texas at Austin. In a new study published Wednesday in the journal Science Translational Medicine, the researchers report that their handheld device (which is not yet FDA-approved) uses tiny droplets of water to analyze human tissue samples for cancer with 96% accuracy.

 

“It’s a gentle, simple chemical process,” says study author Livia Schiavinato Eberlin , an assistant professor of chemistry at UT Austin. “It’s highly specific and highly sensitive. The fact that it’s non-destructive brings a new approach to cancer diagnosis.”

MORE: Researchers Find a Way to Light Up Cancer Cells

Getting rid of all cancerous tissue while also preventing any harm to healthy tissue is a delicate process. When operating on a woman with breast cancer, for example, a doctor needs to remove the tumor and other affected tissues while maintaining the rest of the breast. Currently there are other tools available to surgeons for tissue diagnosis, but many use gases or solvents that can be harmful for the human body. In 2016, researchers in Massachusetts reportedthat they developed a probe that can find and light up cancer cells, making them easier for surgeons to see. But other methods currently available to surgeons today are slower than the MasSpec Pen, the study authors say, in some cases by 30 minutes or more.

Human cells produce a variety of small molecules, and cancer creates a unique set of them that can be used for pattern identification. The MasSpec Pen produces a small drop of water that extracts molecules from a person’s cells during surgery. Through machine learning, the MasSpec Pen is able to determine what molecular fingerprint is normal and what is cancer, Eberlin says.

In the study, the researchers tested 253 human tissue samples from lung, ovary, thyroid and breast cancer tumors and compared them to samples of healthy tissues. The device was 96% accurate at identifying cancerous tissues. The researchers also tested the MasSpec Pen in live mice with tumors and found that the device was able to identify the presence of cancer without harming healthy surrounding tissues. The device can also identify different subtypes of lung and thyroid cancer, and the team hopes to make it more specified for other types of cancer, too.

 

The researchers say they need to continue validating their work and that they plan to start clinical testing in humans in 2018. Until then, it’s unclear how exactly the device will work when integrated into surgery. While the pen-sized device that the surgeon would use is small, the device is connected to a large mass spectrometer, which helps the process of analyzing individual molecules . That large machine would need to be wheeled in and out of a surgery room for each procedure. The pen is disposable, so surgeons would replace it with each surgery.

“This is a good example of a tool that empowers our transition to precision medicine where the treatment can be done with much higher levels of confidence,” says study author Thomas Milner, professor of biomedical engineering in UT Austin's Cockrell School of Engineering . “Treatment can be planned and given where the outcomes are known. This is one tool along that path.”

http://time.com/4928010/diagnose-cancer-pen/

疑難排解

會員註冊


或許你會想看
【醫療新知】科技園創科社群逾30創新醫療方案 亮相醫療健康周吸引投資者目光
  科技園創科社群逾30創新醫療方案  亮相醫療健康周吸引投資者目光 公開亮相包括癌症測試及心血管疾 […]
「1+」新機制 兩治癌新藥准在港註冊
特區政府推出「1+」新藥審批機制實施後,已有兩款癌症新藥獲批准在香港註冊,讓更多本地病人受惠。醫院管理局表示, […]
【北上求診】政府延續「支援粵港澳大灣區醫院管理局病人先導計劃」至明年三月底
醫務衞生局(醫衞局)今日(三月七日)公布,「支援粵港澳大灣區醫院管理局病人先導計劃」(先導計劃)會延續至明年三 […]
【醫學研究】港大醫學院研究顯示太極有效改善晚期肺癌患者睡眠質素
晚期肺癌患者睡眠障礙及心理症狀 影響整體存活率 肺癌一直是香港最常見的癌症,亦是主要的癌症死因。晚期肺癌患者長 […]
FDA批准首個靶向HER2陽性跨癌種治療藥Enhertu
近日,美國FDA批准了一款針對轉移性HER2陽性實體瘤的靶向藥物,這意味著該類患者無論是哪種癌症類型以及癌細胞 […]
【中西醫協作】醫務衞生局委任中醫藥發展專員
醫務衞生局(醫衞局)今日(四月十日)宣布,經公開招聘後,委任鍾志豪博士為中醫藥發展專員。任期由二○二四年五月二 […]
【癌症研究】中大醫學院研究應對肝癌免疫治療的抗藥性
原發性肝癌是全球第四大及香港第三大致命癌症。2021年,本港有超過1,400人死於肝癌。對於無法進行切除腫瘤手 […]
【癌症治療】綠葉製藥創新葯在港澳門上市 小細胞肺癌二線治療迎來新突破
2024年3月7日,中國香港&中國澳門——由香港腫瘤治療學會主辦、綠葉製藥集團支持的“小細胞肺癌(SC […]
【醫學研究】中大研究發現咽峽炎鏈球菌可引致胃癌
香港中文大學(中大)醫學院最新研究發現一種名為「咽峽炎鏈球菌」(Streptococcus anginosus […]
【醫學研究】癌症治療新突破:港大醫學院研製雙重抗腫瘤疫苗
香港大學李嘉誠醫學院(港大醫學院)的研究團隊發現,從 γδ-T 細胞中提取的外泌體不僅具有直接的抗腫瘤效果,在 […]
【大灣區醫療】首間港資深圳私人綜合醫院 盼縮短港人治療輪候時間 |深圳新風和睦家醫院介紹
本港公營醫療服務供不應求,導致病人長期輪候成常態。近期港人流行「北上消費」,除了吃喝玩樂,「北上醫療」亦是「北 […]
【大灣區醫療】深圳新風和睦家醫院與保誠保險簽署跨境保險業務合作,進一步拓展大灣區醫療網絡服務
深圳新風和睦家醫院(以下簡稱「和睦家」)與保誠保險有限公司(以下簡稱「保誠」)今日簽署戰略性的直接合作,保誠成 […]